Your Article Summary
Oral Methotrexate/6-mercaptopurine may be Superior to a Multidrug LSA2L2 Maintenance Therapy for Higher Risk Childhood Acute Lymphoblastic Leukemia: Results From the NOPHO ALL-92 Study
Journal of Pediatric Hematology/Oncology, 07/01/09
Schmiegelow K et al. - These results indicate that oral MTX/6MP maintenance therapy administered after the first year of remission can improve the cure rates of children with T-lineage or with higher risk B-lineage ALL.
Related Articles
Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia
Blood, 11/13/09
Relevance Score: 81%
T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics and outcome from the large randomised prospective trial (UKALL XII/ECOG 2993)
Blood, 11/02/09
Relevance Score: 81%
Refractory chronic immune thrombocytopenic purpura in a child with acute lymphoblastic leukemia
International Journal of Hematology, 10/13/09
Relevance Score: 81%
Outcome of childhood acute lymphoblastic leukemia with induction failure treated by the Japan Association of Childhood Leukemia Study (JACLS) ALL F-protocol
Pediatric Blood & Cancer, 10/09/09
Relevance Score: 81%
Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial
Haematologica, 10/07/09
Relevance Score: 80%
Today in Pediatrics...keeping you current
Receive free subspecialty "5-minute updates" via email
Socio-economic inequalities in childhood mortality in low- and middle-income countries: a review of the international evidence
British Medical Bulletin, 12/10/09
Attitudes of Adolescent Cancer Survivors Toward End-of-Life Decisions for Minors
Pediatrics, 12/10/09
Association Between Adherence and Glycemic Control in Pediatric Type 1 Diabetes
Pediatrics, 12/10/09

See Latest Articles